Info Conferences invites all the participants from all over the world to attend the “International Conference on Neurology and Neurodisorders” (Neurodisorders Congress 2025), which will be held on March 17-18, 2025, in Amsterdam, Netherlands. The main theme of our conference is "Advances in Neurotherapeutics and Disease Modification," which will cover wide range of critically important sessions.
Neurodisorders congress 2025 mainly focuses on spreading the awareness about challenges in this field and how to prevent Neurological diseases. We organizes a Conference Series llc LTD of 1000+ Global events, inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. World-renowned speakers, the most recent techniques, developments, and the newest updates in neurology are hallmarks of this conference.
Benefits of Participation:
Who should attend?
Conference Highlights:
Benefits of Participation
Advantages of Participating at our conference:
Benefits of Participation | Speaker
Benefits of Participation | Sponsor
Benefits of Association for Collaborators
Benefits of Participation: Delegate
Market Analysis
The largest and least-explored market in the medical industry is represented by the market analysis of Neurology 2024. This evaluated market study is based on statistical trends, product promotion, and the likelihood of product endorsement and sales in late stages of development. Once more, the emerging market contributes to increased sales. CNS treatments accounts for around 25% of all pharmaceutical transactions, or $30 billion globally. Anxiety disorders, depression, and schizophrenia are estimated to cost $47 billion, $44 billion, and $33 billion annually, respectively.
Understanding the market value and projected growth of Neurology drugs, as well as the current economic cost of research and development, is the goal of this session. In addition to the increase in patients, there is still a sizable unmet demand in the management of several Neurological illnesses. Alzheimer's disease presents the biggest financial opportunity for pharmaceutical companies in Neurology due to its potential to be one of the most lucrative therapeutic areas later on in the Pharmaceutical industry. The loss of patent protection or market exclusivity for a significant number of therapeutic medications used to treat Neurological illnesses has opened up new research and business possibilities for rival pharmaceutical and medical device firms.
A glance at the market for neuroscience:
Demand for the neuroscience sector was valued at USD 24.09 billion in 2014, and it is expected to surpass USD 30.80 billion by 2022. The creation of many Neuro neuroinformatics solutions as a consequence of increased R&D spending and substantial government financing are the main drivers of market expansion. Designing and creating effective tools and algorithms that can improve the performance of structural and functional mapping is part of Neuroinformatics. Over the following seven years, the neuroscience market is anticipated to develop at a CAGR of 2.8%.
The need for fresh developments in the Neurology field has grown as a result of the increasing prevalence of malignant conditions like Parkinsonism and Alzheimer's disease, as well as other hereditary CNS disorders. Due to rising demand in labs and academic institutions, the market is anticipated to expand throughout the given time frame. The market wants to introduce cutting-edge technology that can provide insights into how the brain and complex Nervous system operate. Due to a growing desire for improved medications, it is projected that an annual increase in the total number of elderly people would greatly increase demand.
When the brain and spine's sensory systems are impacted, a neurological condition results. Alcohol and drugs are the main risk factors that contribute to illnesses. Only four medications are available to treat Alzheimer's symptoms, and 99% of all therapies through clinical trials are never approved. A recent estimate projects that the neuroscience industry will reach USD 30.8 billion by 2020. The top countries in Europe for the sale of medications for Neurodisorders 2024 are Germany, the United States, France, Switzerland, Italy, and Spain. The market demand for neurological medications has increased due to the prevalence of neurological illnesses such epilepsy, Parkinson's disease, Alzheimer's disease, multiple sclerosis, schizophrenia, traumatic brain injury, spinal cord injury, and cerebrovascular diseases. Compared to US$18.3 billion in 2015, the European market is predicted to reach US$32.0 billion by the end of 2025.
Epilepsy had the most medicine sales at the World Neuroscience and Neurology Conference, followed by conditions like Alzheimer's, Parkinson's, Multiple Sclerosis, Cerebrovascular disease, and others.
NND 2025 will be an invaluable resource for Mental Health Psychiatrists, Psychologists, Students, Psychiatrist, Research Scholars, Educators, Nurses, Caregivers, Surgeons, Diagnostic laboratory professionals, Industry Professionals, Business Entrepreneurs, Healthcare Professionals and other healthcare professions & practitioners across various therapeutic and research areas.
Wednesday - Oct 30, 2024
08:00 - 09:00
Registration at Desk
09:00 - 09:30
Opening Ceremony
10:00-11:00
Keynote Forum
11:00 - 11:15
Refreshments & Networking
11:15 - 12:15
Keynote Forum
12:15 - 13:00
Session 1 (Oral Presentation)
13:00 - 14:00
Lunch Break
14:00 - 15:30
Session 2 (Oral Presentation)
15:30 - 15:45
Refreshments & Networking
15:45 - 17:00
Session 3 (Oral Presentation)
Thursday - Oct 31, 2024
10:00 - 11:00
Keynote Forum
11:00 - 11:15
Refreshments & Networking
11:15 - 12:15
Keynote Forum
12:15 - 13:05
Session 4 (Oral Presentation)
13:05 - 14:00
Lunch Break
14:00 - 15:00
Workshop/Symposium
15:00 - 15:30
Emering Researcher Forum
15:30 - 15:45
Refreshments & Networking
15:45 - 16:30
Emering Researcher Forum
16:30 - 17:30
Poster Presentations
Certicate felicitation & Award Cermony
Disclaimer: The scientific committee reserve the right to make changes to the programme without prior notice in the best interest of the conference (Tentative Scientific Program)